BAY-364  (Synonyms: BAY-299N)

BAY-364 (BAY-299N) is an inhibitor of the second bromine domain in TAF1. BAY-364 inhibits the TAF1 of Kasumi-1 cells, CD34⁺ cells and K562 cells with IC₅₀ values of 1.0 µM, 10.4 µM and 10.0 µM respectively^[1].

BAY-364 (0.1-100 µM; 3 d) inhibits the growth of Kasumi-1 cells, CD34⁺ cells and K562 cells^[1].
BAY-364 (72 h) decreases the expression of ID1, MYC and TAF1 but insignificantly affect the expression of AE in the Kasumi-1 cells^[1].
BAY-364 (10 µM; 2 d) reduces colony formation in AE9a⁺ cells^[1].
BAY-364 (2 µM; 48 h and 72 h) has insignificant effect on the cell cycle of K562 cells^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

401.41

C₂₃H₁₉N₃O₄

2097610-30-3

O=C1NC2=CC(N3C(C4=CC=CC5=C4C(C3=O)=CC=C5CCCO)=O)=CC=C2N1C

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Xu Y, et al. TAF1 plays a critical role in AML1-ETO driven leukemogenesis. Nat Commun. 2019 Oct 29;10(1):4925.  [Content Brief]

  [2]. Garcia-Carpizo V, et al. Therapeutic potential of TAF1 bromodomains for cancer treatment[J]. bioRxiv, 2018: 394254.